ArticleWorld journal of clinical cases2021

Non-small-cell lung cancer with epidermal growth factor receptor L861Q-L833F compound mutation benefits from both afatinib and osimertinib: A case report.

Yao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.